腰大肌面积在筛选适合胸主动脉腔内修复术的老年患者中的效用
回顾性分析105例75岁及以上因降主动脉瘤行择期胸主动脉腔内修复术的患者,按腰大肌质量指数分为肌少症组与非肌少症组。肌少症组5年总生存率46%(95%CI 29%-73%),非肌少症组84%(95%CI 74%-94%);肌少症是全因死亡的独立危险因素(校正HR 2.64;95%CI 1.02-6.82;P=.045)。
要点
- 38例(36%)患者被归类为肌少症。
- 肌少症组5年总生存率46%(95%CI 29%-73%),非肌少症组84%(95%CI 74%-94%)。
- 肌少症是全因死亡的独立危险因素(校正HR 2.64;95%CI 1.02-6.82;P=.045)。
核心结论
- 腰大肌质量指数可能是因降主动脉瘤行择期胸主动脉腔内修复术的老年患者死亡的良好预测指标。
研究设计与样本
- 回顾性研究,纳入2010年1月至2019年12月期间105例75岁及以上因降主动脉瘤行择期胸主动脉腔内修复术的患者。
- 术前CT在L3水平测量腰大肌面积,除以身高平方得出腰大肌质量指数。
- 患者分为肌少症组与非肌少症组,肌少症定义为男性腰大肌质量指数<5.40 cm²/m²、女性<3.56 cm²/m²。
- 采用单样本对数秩检验与年龄和性别匹配的一般人群比较总生存率。
- 采用倾向评分校正的Cox比例风险模型确定全因死亡的风险比。
主要发现
- 随访期间(中位3年)23例患者死亡。
- 38例(36%)患者被归类为肌少症。
- 肌少症组5年总生存率46%(95%CI 29%-73%),非肌少症组84%(95%CI 74%-94%)。
- 肌少症组总生存率显著低于其匹配的一般人群(P=.004),非肌少症组与其匹配的一般人群总生存率无统计学显著差异(P=.417)。
- 肌少症是全因死亡的独立危险因素(校正HR 2.64;95%CI 1.02-6.82;P=.045)。
关键数值与推荐
- 肌少症定义:男性腰大肌质量指数<5.40 cm²/m²,女性<3.56 cm²/m²。
- 肌少症组5年总生存率46%(95%CI 29%-73%),非肌少症组84%(95%CI 74%-94%)。
- 肌少症组与其匹配的一般人群总生存率比较P=.004,非肌少症组与其匹配的一般人群比较P=.417。
- 肌少症对全因死亡的校正HR 2.64(95%CI 1.02-6.82;P=.045)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The impact of psoas muscle area on overall survival is unknown for older patients undergoing elective thoracic endovascular aortic repair. METHODS: We retrospectively reviewed 105 patients aged 75 years or more who underwent elective thoracic endovascular aortic repair for descending thoracic aortic aneurysm between January 2010 and December 2019. Psoas muscle area was measured at the L3 level with preoperative computed tomography and adjusted by height squared to derive psoas muscle mass index. The patients were stratified into two groups, sarcopenia and nonsarcopenia. sarcopenia was defined as a psoas muscle mass index less than 5.40 cm2/m2 for men and less than 3.56 cm2/m2 for women. The overall survival was compared with the age- and sex-matched general population using the one-sample log rank test. The propensity score adjusted Cox proportional hazards model was applied to determine the hazard ratio for all-cause mortality. RESULTS: Twenty-three patients died during the follow-up period (median, 3 years). Thirty-eight patients (36%) were classified as sarcopenia. The 5-year overall survival rate was 46% (95% confidence interval, 29% to 73%) for sarcopenia and 84% (95% confidence interval, 74% to 94%) for nonsarcopenia. The overall survival was significantly lower in the sarcopenia group than in its matched general population (P = .004), whereas no statistically significant difference in overall survival was found between the nonsarcopenia group and its matched general population (P = .417). Sarcopenia was an independent risk factor for all-cause mortality (adjusted hazard ratio 2.64; 95% confidence interval, 1.02 to 6.82; P = .045). CONCLUSIONS: Psoas muscle mass index may be a good predictor of mortality among older patients undergoing elective thoracic endovascular aortic repair for descending thoracic aortic aneurysm.
引用
- Ouchi T, Kato N, Kato H, et al. Utility of Psoas Muscle Area in Selecting Older Patients Feasible for Thoracic Endovascular Aortic Repair. Ann Thorac Surg. 2022. PMID: 35216989. doi:10.1016/j.athoracsur.2022.01.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。